Issa J Dahabreh - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Issa J Dahabreh

Showing results (61-70 of 142) with videos related to

Pageof 15

Sort By:

Leukemia Research|July 18, 2008

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemiaIssa J Dahabreh, Katerina Zoi, Stavroula Giannouli, et al.

Leukemia Research|February 5, 2008

Hypereosinophilic syndrome: another face of janus?Issa J Dahabreh, Stavroula Giannouli, Cristine Zoi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009

Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancerIssa J Dahabreh, Helena Linardou, Fotios Siannis, et al.

The New England Journal of Medicine|January 18, 2018

Elimination of Cost Sharing for Screening Mammography in Medicare Advantage PlansAmal N Trivedi, Bryan Leyva, Yoojin Lee, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008

Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical databaseSamuel Murray, Issa J Dahabreh, Helena Linardou, et al.

Health Services Research|March 8, 2021

Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapiesBora Youn, Ira B Wilson, Vincent Mor, et al.

Cancer|January 17, 2020

Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancerBora Youn, Nikolaos A Trikalinos, Vincent Mor, et al.

Journal of Cardiac Failure|December 31, 2025

Empagliflozin vs. dapagliflozin in heart failure: a target trial emulationKasper Bonnesen, Issa J Dahabreh, Uffe Heide-Jørgensen, et al.

Journal of Comparative Effectiveness Research|November 19, 2013

Modernizing the systematic review process to inform comparative effectiveness: tools and methodsByron C Wallace, Issa J Dahabreh, Christopher H Schmid, et al.

BMJ (Clinical Research Ed.)|November 20, 2014

Law enforcement duties and sudden cardiac death among police officers in United States: case distribution studyVasileia Varvarigou, Andrea Farioli, Maria Korre, et al.

Pageof 15

Search research articles

Showing results (61-70 of 142) with videos related to

Sort By:

Pageof 15

Leukemia Research|July 18, 2008

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemiaIssa J Dahabreh, Katerina Zoi, Stavroula Giannouli, et al.

Leukemia Research|February 5, 2008

Hypereosinophilic syndrome: another face of janus?Issa J Dahabreh, Stavroula Giannouli, Cristine Zoi, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009

Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancerIssa J Dahabreh, Helena Linardou, Fotios Siannis, et al.

The New England Journal of Medicine|January 18, 2018

Elimination of Cost Sharing for Screening Mammography in Medicare Advantage PlansAmal N Trivedi, Bryan Leyva, Yoojin Lee, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008

Health Services Research|March 8, 2021

Population-level changes in outcomes and Medicare cost following the introduction of new cancer therapiesBora Youn, Ira B Wilson, Vincent Mor, et al.

Cancer|January 17, 2020

Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancerBora Youn, Nikolaos A Trikalinos, Vincent Mor, et al.

Journal of Cardiac Failure|December 31, 2025

Empagliflozin vs. dapagliflozin in heart failure: a target trial emulationKasper Bonnesen, Issa J Dahabreh, Uffe Heide-Jørgensen, et al.

Journal of Comparative Effectiveness Research|November 19, 2013

Modernizing the systematic review process to inform comparative effectiveness: tools and methodsByron C Wallace, Issa J Dahabreh, Christopher H Schmid, et al.

BMJ (Clinical Research Ed.)|November 20, 2014

Law enforcement duties and sudden cardiac death among police officers in United States: case distribution studyVasileia Varvarigou, Andrea Farioli, Maria Korre, et al.

Pageof 15